title: [Breast cancer adjuvant endocrine treatment].
abstract: Endocrine treatment of early stage breast cancer may be summarized in two settings. (1) Early breast cancer, premenopausal women: tamoxifen; ovarian suppression is an acceptable option. (2) Early breast cancer, menopausal women: aromatase inhibitors, for at least 2 to 3 years; extended treatment beyond 5 years of tamoxifen may be discussed.
authors.affiliation: Département d'oncologie médicale, Institut Curie, 75005, Paris, France. paul.cottu@curie.fr
authors.forename: Paul
authors.initials: P
authors.lastname: Cottu
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause / Q000502:physiology; D009367:Neoplasm Staging
chemical_list: D018931:Antineoplastic Agents, Hormonal